Unlocking the Genome for Precision Medicine
Next Generation Sequence Pharmacogenomics (PGx) Pipeline
With our NGS PGx pipeline, healthcare providers can tailor specific treatment and prescribe the correct drug dosage based on their patients’ genetic profiles.
Key Features

Comprehensive Genomic Analysis
Performs SNPs detection, infer haplotypes and diplotypes, and genotype/phenotype of PGx genes, including complex genes, e.g., CYP2D6.

Curated Guideline Recommendations
Established guidelines from Clinical Pharmacogenetics Implementation Consortium (CPIC) and Dutch Pharmacogenetics Working Group (PharmGKB-DPWG)

Customisable Report
Customisable PGx report that best aligns with individual requirements. Reports available in HTML, PDF and JSON formats.
How It Works
Our PGx pipeline manages the interpretation of raw genomic data to the predictions of star alleles to expected phenotype and it defines the rules which associate a phenotype with recommended changes to clinical care.

Comprehensive Analysis
Precision Genetic Analysis
SNPs Detection
Identify single nucleotide polymorphisms (SNPs), which can affect how individuals respond to medications.
Haplotype and Diplotype Inference
By analyzing combinations of SNPs, our PGx pipeline infers haplotypes and diplotypes, providing deeper insight into genetic variations and their potential impact on drug response.
Genotyping and Phenotyping
Perform both genotyping and phenotyping to predict how these variants manifest in drug response of PGx genes.
Complex Gene Analysis
Precisely analyse complex genes such as CYP2D6, which play a critical role in drug metabolism, for accurate treatment recommendations.

Curated guideline recommendations
Expert-Driven Guidelines
Our PGx pipeline leverages established guidelines from the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Dutch Pharmacogenetics Working Group (PharmGKB-DPWG) to provide curated, evidence-based recommendations. By integrating these authoritative resources, we ensure that our guidance on drug selection and dosing is both precise and reliable, aligning with the latest standards in pharmacogenomics. This approach empowers healthcare providers to make informed, confident decisions tailored to each patient’s genetic profile, enhancing treatment effectiveness and safety.

Customisable PGx report
Personalised Reporting
- Designed to meet individual requirements
- Enable users to select specific gene and drug combinations
- Tailor report to address particular medical conditions
- Relevant and actionable information from established guidelines
- Customisable report template
Available in:

Integration Capabilities
Seamless Integration with Clinical Pipeline
Our PGx pipeline seamlessly integrates with our clinical pipeline powered by novoClinic, enhancing efficiency and enabling streamlined data exchange. Whether it’s data ingestion, interoperability, or real-time updates, our solution harmonises with novoClinic, ensuring a cohesive and powerful clinical experience.

Across Diverse Medical Fields

Cardiology

Neurology

Oncology

Psychiatry

Pulmonary

Dental

Rheumatology

Gastroenterology

Infectious Disease

Urology

Hematology
